Genedrive plc (GDR) Ordinary 1.5p Shares
Share news, reports & tips
22 May 2020 13:16
(Sharecast News) - Molecular diagnostics company Genedrive announced on Friday that its 'Genedrive 96 SARS-CoV-2 Kit' was now CE-IVD marked, and available for commercial sale across the European...
1 May 2020 16:17
(Sharecast News) - Near-patient molecular diagnostics company Genedrive has completed the last significant manufacturing milestone in the co-development of the 'Genedrive 96 SARS-CoV-2' kit with...
3 December 2019 09:39
(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Tuesday that in its case-control clinical validation, the antibiotic-induced hearing loss assay - the 'Genedrive...
18 November 2019 16:00
(Sharecast News) - Molecular diagnostics company Genedrive announced on Monday that its antibiotic-induced hearing loss test, the 'Genedrive MT-RNR1 ID' kit, has obtained CE marking.
3 October 2019 10:41
(Sharecast News) - Genedrive on Thursday reported a narrowed annual loss as revenues jumped as its commercial relationship with the US department of defense (DoD) exceeded expectations.
28 March 2019 07:59
(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tick ahead slightly in the first half of its financial year but increased research and development costs kept the firm in the red.
15 January 2019 10:17
(Sharecast News) - Near-patient molecular diagnostics company Genedrive issued an unaudited update for the six months ended 31 December on Tuesday, reporting revenue of £1.5m, up from £1.3m year-on-year.
29 November 2018 11:49
(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Thursday that it will participate in an international multicentre trial, designed to assess the impact of outreach HCV...
16 November 2018 08:38
(Sharecast News) - Molecular diagnostics specialist Genedrive plans to raise cash to support development of its hepatitis C tool after annual losses widened a touch despite an uptick in revenue and other...
13 July 2018 08:45
(Sharecast News) - Molecular diagnostics company Genedrive said it was applying £2m of additional non-dilutive grant funding to progress key development programmes, as it provided investors with a trading...
20 June 2018 14:56
(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced the receipt of a multi-partner grant award from the UK National Institute for Health Research's Invention for Innovation...
9 April 2018 10:45
(ShareCast News) - AIM-quoted near-patient molecular diagnostics company Genedrive has appointed Tom Lindsay as a non-executive director, effective immediately.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2020. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.